TENOFOVIR

Clinical trials for TENOFOVIR explained in plain language.

Never miss a new study

Get alerted when new TENOFOVIR trials appear

Sign up with your email to follow new studies for TENOFOVIR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New study tests rectal gel as a discreet HIV prevention option

Prevention Ongoing

This study tests two ways to prevent HIV: a rectal gel and oral pills, both taken only when needed. About 150 men will try each method for 8 weeks to see which is safer, easier to use, and preferred. The goal is to offer more choices for HIV prevention.

Matched conditions: TENOFOVIR

Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention

Last updated May 17, 2026 05:08 UTC

TENOFOVIR

Get alerted when new TENOFOVIR trials appear

New study tests rectal gel as a discreet HIV prevention option